Skip to main content
. 2009 Nov 6;10(12):1355–1362. doi: 10.1038/embor.2009.233

Figure 5.

Figure 5

Involvement of MMP9 in intestinal adenoma formation. (A) The effects of the MMP9-specific inhibitor, ZA, on intestinal adenoma formation in ApcMin/+ mice (n=5–7 per genotype). *P<0.05. (B) Suppression of MMP9 gelatinase activity by ZA in vivo. Lysates from spleens of control and ZA-treated ApcMin/+ mice were subjected to gelatine zymography for MMP9. MMP9, matrix metalloproteinase 9; ZA, zoledronic acid; zymo, gelatin zymography.